Patents by Inventor Stephane Naudin
Stephane Naudin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9974550Abstract: A tibia cutting block for performing precise cuts into a tibia comprises an approximately cuboid body with a tibia attachment side and opposing thereto a front side. The body has a cutting guide slot extending from a top side into the body, a blade holding slot extending from a right side or a left side into the body, a first anchoring pin hole which is close to the intersection of a first plane defined by the blade holding slot and a second plane defined by the a cutting guide slot, a second anchoring pin hole distant from the first anchoring pin hole and a reference pin guide. All are penetrating the body from the front side to the tibia attachment side.Type: GrantFiled: August 24, 2015Date of Patent: May 22, 2018Assignee: ARTHREX, INC.Inventors: Gerd Seitlinger, Florian Dirisamer, Uta Moll, Stéphane Naudin, Frank Uhing, Michel Gerlinde
-
Patent number: 9610167Abstract: A glenoid implant has an anatomically formed body including of metal and/or plastic materials. It further has a contact surface adapted to extend the surface of a glenoid and to bear a humerus. In the implant body, there is at least one hole with a screw head seating area for holding the head of a screw, which may be screwed into a glenoid for fixedly attaching the glenoid implant.Type: GrantFiled: December 10, 2015Date of Patent: April 4, 2017Assignee: Arthrex, Inc.Inventors: Philippe Hardy, Stéphane Naudin
-
Patent number: 9486317Abstract: Methods of arthroscopic resurfacing of a joint utilizing a biological component strengthened with fibrin glue. The biological component is selected from the group consisting of PRP, bone marrow aspirate (BMA) and autologous conditioned plasma (ACP). The biological component/fibrin glue composition may be inserted (by injection or by employing a biologic resurfacing mold, for example) into a transosseous tunnel in the vicinity of the defect to be repaired. Upon insertion at the defect site, the biological component/fibrin glue composition is designed to coagulate and solidify within few minutes, to advance the healing of the damaged tissue and tissue growth. The biological component/fibrin glue composition may optionally comprise components such as growth factors, antiseptic chemicals and/or antibiotics and/or electrolytes, or hormones or site-specific hybrid proteins, among others.Type: GrantFiled: August 26, 2008Date of Patent: November 8, 2016Assignee: Arthrex Inc.Inventors: Giuseppe Milano, Gerlinde Michel, Stephane Naudin, Hans Linden, Reinhold Schmieding
-
Publication number: 20160095709Abstract: A glenoid implant has an anatomically formed body including of metal and/or plastic materials. It further has a contact surface adapted to extend the surface of a glenoid and to bear a humerus. In the implant body, there is at least one hole with a screw head seating area for holding the head of a screw, which may be screwed into a glenoid for fixedly attaching the glenoid implant.Type: ApplicationFiled: December 10, 2015Publication date: April 7, 2016Inventors: Philippe Hardy, Stéphane Naudin
-
Publication number: 20160051268Abstract: A tibia cutting block for performing precise cuts into a tibia comprises an approximately cuboid body with a tibia attachment side and opposing thereto a front side. The body has a cutting guide slot extending from a top side into the body, a blade holding slot extending from a right side or a left side into the body, a first anchoring pin hole which is close to the intersection of a first plane defined by the blade holding slot and a second plane defined by the a cutting guide slot, a second anchoring pin hole distant from the first anchoring pin hole and a reference pin guide. All are penetrating the body from the front side to the tibia attachment side.Type: ApplicationFiled: August 24, 2015Publication date: February 25, 2016Applicant: Arthrex, Inc.Inventors: Gerd Seitlinger, Florian Dirisamer, Uta Moll, Stéphane Naudin, Frank Uhing, Michel Gerlinde
-
Patent number: 9216091Abstract: A glenoid implant has an anatomically formed body including of metal and/or plastic materials. It further has a contact surface adapted to extend the surface of a glenoid and to bear a humerus. In the implant body, there is at least one hole with a screw head seating area for holding the head of a screw, which may be screwed into a glenoid for fixedly attaching the glenoid implant.Type: GrantFiled: February 26, 2013Date of Patent: December 22, 2015Assignee: Arthrex, Inc.Inventors: Philippe Hardy, Stéphane Naudin
-
Patent number: 8535703Abstract: Methods of arthroscopic resurfacing of anatomical tissue utilizing a biological component strengthened with glue or similar material. The biological component is selected from the group consisting of blood, blood components, PRP, bone marrow aspirate (BMA) and autologous conditioned plasma (ACP). The biological component/glue composition may be inserted (by injection and/or by employing a biologic resurfacing mold, for example) into, or in the vicinity of, the anatomical tissue. Upon insertion within, or contact with, the anatomical tissue, the biological component/glue composition is designed to coagulate and solidify (or partially solidify) within minutes, to advance healing or tissue growth of the anatomical tissue. The biological component/glue composition may optionally comprise components such as growth factors, antiseptic chemicals and/or antibiotics and/or electrolytes, or hormones or site-specific hybrid proteins, among others.Type: GrantFiled: August 26, 2008Date of Patent: September 17, 2013Assignee: Arthrex, Inc.Inventors: Reinhold Schmieding, Gerlinde Michel, Stephane Naudin, Hans Linden
-
Publication number: 20130238099Abstract: A glenoid implant has an anatomically formed body including of metal and/or plastic materials. It further has a contact surface adapted to extend the surface of a glenoid and to bear a humerus. In the implant body, there is at least one hole with a screw head seating area for holding the head of a screw, which may be screwed into a glenoid for fixedly attaching the glenoid implant.Type: ApplicationFiled: February 26, 2013Publication date: September 12, 2013Applicant: Arthrex, Inc.Inventors: Philippe Hardy, Stéphane Naudin
-
Patent number: 8348960Abstract: A technique for joint repair employing a suture/button construct and an applicator designed to securely engage a button of the suture/button construct. The button of the suture/button construct securely engages the shaft of the applicator. The suture from the button may be wrapped around a securing device (for example, a rod or bolt) located on or within the handle. The applicator with the secured button is introduced into the tissue (for example, soft tissue or a bone tunnel) and the button is passed through the tissue.Type: GrantFiled: July 3, 2008Date of Patent: January 8, 2013Assignee: Arthrex, Inc.Inventors: Gerlinde Michel, Benedikt Bodinger, Karen L. Gallen, Stephane Naudin
-
Patent number: 8052969Abstract: A method of providing autologous conditioned plasma (ACP) for treatment of connective tissue injuries. The method comprises the steps of: (i) providing an apparatus comprising a centrifuge and a double syringe, the double syringe including an inner syringe body and an outer syringe body; (ii) drawing autologous blood into the outer syringe body; (iii) subjecting the autologous blood to at least one centrifugation step to obtain an autologous conditioned plasma (ACP); (iv) removing, with the inner syringe body, at least a portion of autologous conditioned plasma (ACP) from the outer syringe body; and (v) inject ACP for treatment of various cartilage or tendon damage or diseases.Type: GrantFiled: December 21, 2007Date of Patent: November 8, 2011Assignee: Arthrex, Inc.Inventors: Michael Buhr, Werner Siekmann, Stèphane Naudin
-
Publication number: 20090062870Abstract: Methods of arthroscopic resurfacing of a joint utilizing a biological component strengthened with fibrin glue. The biological component is selected from the group consisting of PRP, bone marrow aspirate (BMA) and autologous conditioned plasma (ACP). The biological component/fibrin glue composition may be inserted (by injection or by employing a biologic resurfacing mold, for example) into a transosseous tunnel in the vicinity of the defect to be repaired. Upon insertion at the defect site, the biological component/fibrin glue composition is designed to coagulate and solidify within few minutes, to advance the healing of the damaged tissue and tissue growth. The biological component/fibrin glue composition may optionally comprise components such as growth factors, antiseptic chemicals and/or antibiotics and/or electrolytes, or hormones or site-specific hybrid proteins, among others.Type: ApplicationFiled: August 26, 2008Publication date: March 5, 2009Inventors: Giuseppe Milano, Gerlinde Michel, Stephane Naudin, Hans Linden, Reinhold Schmieding
-
Publication number: 20090060974Abstract: Methods of arthroscopic resurfacing of anatomical tissue utilizing a biological component strengthened with glue or similar material. The biological component is selected from the group consisting of blood, blood components, PRP, bone marrow aspirate (BMA) and autologous conditioned plasma (ACP). The biological component/glue composition may be inserted (by injection and/or by employing a biologic resurfacing mold, for example) into, or in the vicinity of, the anatomical tissue. Upon insertion within, or contact with, the anatomical tissue, the biological component/glue composition is designed to coagulate and solidify (or partially solidify) within minutes, to advance healing or tissue growth of the anatomical tissue. The biological component/glue composition may optionally comprise components such as growth factors, antiseptic chemicals and/or antibiotics and/or electrolytes, or hormones or site-specific hybrid proteins, among others.Type: ApplicationFiled: August 26, 2008Publication date: March 5, 2009Inventors: Reinhold Schmieding, Gerlinde Michel, Stephane Naudin, Hans Linden
-
Publication number: 20090043318Abstract: A technique for joint repair employing a suture/button construct and an applicator designed to securely engage a button of the suture/button construct. The button of the suture/button construct securely engages the shaft of the applicator. The suture from the button may be wrapped around a securing device (for example, a rod or bolt) located on or within the handle. The applicator with the secured button is introduced into the tissue (for example, soft tissue or a bone tunnel) and the button is passed through the tissue.Type: ApplicationFiled: July 3, 2008Publication date: February 12, 2009Inventors: Gerlinde Michel, Benedikt Bodinger, Karen L. Gallen, Stephane Naudin
-
Publication number: 20080166421Abstract: A method of providing autologous conditioned plasma (ACP) for treatment of connective tissue injuries. The method comprises the steps of: (i) providing an apparatus comprising a centrifuge and a double syringe, the double syringe including an inner syringe body and an outer syringe body; (ii) drawing autologous blood into the outer syringe body; (iii) subjecting the autologous blood to at least one centrifugation step to obtain an autologous conditioned plasma (ACP); (iv) removing, with the inner syringe body, at least a portion of autologous conditioned plasma (ACP) from the outer syringe body; and (v) inject ACP for treatment of various cartilage or tendon damage or diseases.Type: ApplicationFiled: December 21, 2007Publication date: July 10, 2008Inventors: Michael Buhr, Werner Siekmann, Stephane Naudin